Post by The Market Bull - Daily Stock News
5,802 followers
π₯ TruScreen Group Limited's (ASX:TRU) CEO Martin Dillon joins Matthew Craig to discuss its world leading AI enabled cervical cancer screening device. It follows their recent successful capital raise of A$1.52M. π° β Multiple studies are ongoing, targeting lower-middle income countries where screenings are far more inefficient. π TruScreen also announced a year of growth, achieving a product sales growth of 42% YOY to FY2026. #ASX #ASXNews #Investing #Biotech Subscribe to the weekly Stock Market Newsletter www.themarketbull.com.au
Video Content